Frontwalker (FRWA) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Completed restructuring with sale of Tavana IT and focus on core segment Solve; new leadership in place for growth phase.
Q2 and H1 results heavily impacted by one-time costs from divestments and continued market headwinds.
Company expects gradual market recovery and aims for positive results in late 2024.
Financial highlights
Q2 2024 net sales SEK 13.0m, down 48% year-over-year; H1 2024 net sales SEK 31.2m, down 44%.
Q2 EBITA SEK -2.4m (improved from -3.9m); H1 EBITA SEK -16.0m (vs -2.7m), including SEK -11.9m one-off from Tavana IT sale.
Q2 net result SEK -2.3m (vs -4.0m); H1 net result SEK -15.9m (vs -2.8m).
Q2 EPS SEK -0.02 (vs -0.03); H1 EPS SEK -0.13 (vs -0.02).
Cash flow from operations H1 SEK -5.7m (vs 1.5m); available liquidity at period end SEK 9.3m.
Outlook and guidance
Market remains challenging with long sales cycles and price pressure, but signs of stabilization as inflation and rates ease.
Several new projects expected to start in autumn, with positive impact anticipated in late 2024.
Targets for 2025: net sales of SEK 154m and EBITA of SEK 11m (7% margin).
Latest events from Frontwalker
- Sales fell 27.5% in 2025; E-Consulate acquisition and AI focus set stage for turnaround.FRWA
Q4 202512 Feb 2026 - Net sales dropped 32% and losses narrowed as strategic shifts and new capital support future growth.FRWA
Q3 20256 Nov 2025 - Revenue declined sharply but new Ventures and capital raise support a turnaround strategy.FRWA
Q2 202514 Aug 2025 - Revenue down 47% and EBITA at SEK -19.1m; new growth strategy and targets set for 2027.FRWA
Q3 202413 Jun 2025 - Revenue halved and losses widened in 2024, but new strategy targets strong recovery by 2027.FRWA
Q4 20246 Jun 2025 - Losses narrowed and new ventures launched as Frontwalker targets a return to growth.FRWA
Q1 20256 Jun 2025